Ascend to Shut Down Lianyungang Plant Within Months Optimizing Regional Operations
On June 17, 2025, Ascend Performance Materials announced its decision to begin an orderly shutdown of its hexamethylene diamine production facility in Lianyungang, China. This decision follows a thorough assessment of the plant’s long-term feasibility amid shifting market trends and regulatory challenges.
Phil McDivitt, Ascend’s President and CEO, stated: “As we continue our focus on operational efficiency, Ascend has made significant progress in improving its business. In April, we initiated the Chapter 11 process with support from our creditors to reduce debt and prepare for future growth. After carefully analyzing market dynamics and ongoing trade disputes, we determined that shutting down the Lianyungang plant is the most efficient path to support customers in the region.”
He added: “Decisions impacting employees are never easy. The Lianyungang team has consistently demonstrated outstanding dedication and professionalism, and we deeply appreciate their contributions. This decision does not reflect their hard work. We are committed to providing support for affected employees and ensuring a smooth transition for our customers and partners.”
Throughout the closure, Ascend will adhere to strict safety, environmental, and compliance standards, working closely with local authorities to meet all regulatory requirements. The company expects to finalize the shutdown within the coming months.
Other Ascend operations in China, including its facility in Suzhou, will continue operating as usual. The company remains focused on delivering high-quality, high-performance products to its global customers and anticipates completing the Chapter 11 process by the second half of this year, positioning itself for future success.
2026-08-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Roche Keeps German Diagnostics Investment
-
BASF and Encina Bet on Circular Chemical Feedstocks
-
Shin-Etsu Chemical Invests $218 Million in Rare Earth Refinery as Multiple Countries Accelerate Domestic Production
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
Lotte Merges with HD Hyundai: Can Korea’s Petrochemical First Case Trigger True Restructuring?
-
China’s Agrochemical Role Expands as Global Supply Risks Intensify
-
China’s Agrochemical Role Expands as Global Supply Risks Intensify
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
Mitsubishi Chemical Announces Expansion of Advanced Carbon Fiber Production Capacity in Japan and the United States
-
Pregabalin vs Gabapentin: Differences, Uses, and Side Effects
Recommend Reading
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order
-
When the Chemical Industry Is No Longer Highly Profitable: Sinochem International’s 2.4 Billion Yuan Loss Reveals the Truth About Industry Cycles
-
A Rare Vote of Confidence: INEOS to Invest €250 Million in French Cracker Plant
-
Profit Crushed, Layoffs and Restructuring Follow: What WACKER Chemie’s 2025 Performance Reveals
-
January China MIBK Market Shows a Phased Recovery
-
Raw Material Costs Remain High, Melamine Prices Slightly Increase in China
-
January ammonium sulfate market trend in China shows a strong increase
-
Winter Storms Combined with Geopolitical Tensions Drive Oil Prices Up 3% in a Single Day
-
Chemical Properties and Uses of Tetraetil